ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE Application EP-4248983-A3 European Patent Office 24 Jan 2024
ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE Grant EP-3972987-B1 European Patent Office 07 Jun 2023
Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use… Grant US-11505597-B2 United States of America 22 Nov 2022
ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE Application WO-2021207599-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021